Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Name: Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
Start: 2024-11-12T12:00:00-05:00
End: 2024-11-12T13:00:00-05:00

Regional/Local November 12 12:00 pm to 1:00 pm EST

Home
Events
Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

About This Event

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

In this presentation, topics of discussion are:

Loss of behavior regulation in agitation associated with AD
Monoamine systems in agitation associated with AD pathophysiology
- Norepinephrine
- Serotonin
- Dopamine

Featuring

Becky Wong, PharmD, MBA (OPDC)

Medical Science Director

E. Jeffrey Greenberg, MD

Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute

Dr. Jeffrey Greenberg, a native of Philadelphia, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine. Dr. Greenberg now focuses his practice on Parkinson’s Disease, Dementia, Multiple Sclerosis, and Neuromuscular Disease. Additionally, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.

Becky Wong, PharmD, MBA is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) E. Jeffrey Greenberg, MD is a paid speaker on behalf of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources

Treatment Pathways Across Cultures: Audience Q&A

Podcast January 21, 2025

This podcast is a continuation of the on-demand webinar entitled ‘Treatment Pathways Across Cultures’ that was aired on November 14, 2024, which featured Dr. Mauricio Tohen and Dr. Crystal Clark…
Part 2: Introduction to PTSD

Infographic January 15, 2025

This infographic aims to raise awareness of PTSD in a straightforward manner appropriate for both individuals with lived experience, and health care providers.
Identification of Agitation in Patients with Dementia due to Alzheimer’s Disease: Perspectives from the Primary Care Provider

On-Demand Webinar January 13, 2025

Join us for a discussion with Dr. C. Brendan Montano, as he shares his perspective from the primary care setting on identifying and responding to agitation associated with dementia due…

Event Navigation

« Virtual Event – A Treatment Journey Hospital to Community
GSA 2024 Annual Scientific Meeting »

Join today for instant access to all PsychU content, events, and more!

Membership is free!

"*" indicates required fields

Name*

First Last

Occupational Category*

Specialty*

Adult

Family Medicine

Geriatric

Internal Medicine

Long Term Care

Pediatric

Psychiatry

How did you hear about PsychU?*

Street Address*

Country*

Zip / Postal Code*

City*

State / Province / Region*

Phone Number*

State License Number

NPI Number

State License Number*

NPI Number*

NPI Exception

I certify that I am a Health Care Provider, but I do not have a NPI Number.

Choose Your Unique Login

User Name*

Your username can only contain lowercase letters (a-z) and numbers. Username cannot be the same as email address.

Email*

Enter Email Confirm Email

Password*

Your password must be at least 8 characters Hint: Must use combination of lower case letters, upper case letters, numbers and special characters like !@#$.

Enter Password Confirm Password

I AGREE TO THE FOLLOWING TERMS

I agree to the following terms:*

I certify that I am a physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and/or manager of an organization and that my primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. I understand that any services and information provided on this website are supplied as a professional courtesy and I must continue to form my own conclusions and make my own decisions. I am also aware that Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka America Pharmaceutical, Inc. and their designees (“Otsuka”) intend to regularly revise this website and reserve the right to decline membership to individuals who Otsuka determines do not meet the aforementioned certification requirements.

I agree to the following terms*

By providing your name, email address, and other information, you are giving Otsuka and companies working with Otsuka permission to send you information from PsychU. Otsuka will not sell or transfer your personal information to any unaffiliated third party, without your prior written consent. Otsuka may monitor your use of the PsychU website to provide you with complimentary information about relevant educational programs based on your use the PsychU website. You agree that, should you use any material provided through PsychU you will attribute the source of that information to “PsychU sponsored by Otsuka Pharmaceutical Development & commercialization, Inc.” For additional information about how Otsuka uses your personal information, how to amend or delete your information, and how to opt out of future communications, please read Otsuka’s Privacy policy, which can be found here. By clicking “Join” and submitting your information, you agree to the terms provided above, and the terms provided in Otsuka’s Terms of Use and Privacy Policy.

Hidden

Direct Care Provider

Direct Care Provider Newsletter

False

Hidden

Clinician Newsletter

False

Hidden

Management Newsletter

False

Hidden

user_preferences_account_notifications

False

Hidden

user_preferences_webinar_emails

False

Event Registration

Submit any questions you may have regarding the topic of this Event and we will try to answer them during the live presentation:

How Did You Hear About This Event*

Date*

MM slash DD slash YYYY

Hidden

otsuka attendence page Event ID

Hidden

Event Page Registration Event ID

Meal Opt Out

Attested*

Attested

(Required)

Signature*

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS

PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community; as such, PsychU is governed in accordance with the PhRMA Code on Interactions with Healthcare Professionals attendance at educational programs.

PSYCHU MEMBERSHIP ELIGIBILITY

In accordance with the PhRMA Code on Interactions with Healthcare Professionals, attendance at PsychU educational programs is limited to appropriate attendees (e.g., physician, clinical professional, current medical school student, care manager, advocate, recovery coach or an executive and manager of an organization) whose primary role is to provide, manage, finance, study, or regulate mental health services for adult patients. NOTE: Otsuka Pharmaceutical Development & Commercialization Inc. (OPDC) reserves the right to decline membership to individuals who OPDC determines do not meet the certification requirements.

MEMBERSHIP & REGISTRATION

Membership is required to attend PsychU programs. Membership is free to all relevant mental health professionals as described above. If you are not currently a member of PsychU, you will need to become a member before you can register to attend an event. Registration for PsychU Live Events will be closed 2 business days prior to the date of the event. No walk-ins will be permitted to attend PsychU Live Events. To become a member and register for a PsychU Program, please visit https://www.PsychU.org/.

ATTENDANCE LIMITATIONS

PsychU declines attendance after a healthcare professional has attended a pre-determined number of programs, has attended multiple programs on the same topic or is outside the appropriate specialty for PsychU programs, to avoid any appearance of impropriety between OPDC and the healthcare professional. This measure protects the healthcare professional as well as OPDC. If you have any questions, please do not hesitate to reach out to the OPDC Ethics and Compliance Department at E&CHelpline@otsuka-us.com.

MEAL REPORTING

The value of all meals provided at PsychU events will be attributed to attendees and reported in accordance with relevant federal and state laws.

Hidden

utm_source

Hidden

initial_source

CAPTCHA

Join PsychU Today to receive a wide array of tools and benefits

Join our multidisciplinary community that is improving mental health care… together
Quickly learn more about the topics you're interested in
Access an award-winning library of on-demand mental health resources
Gain key insights from industry expert & thought leaders

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Thank You For Attending Today’s Webinar

About This Event

Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems

Featuring

Becky Wong, PharmD, MBA (OPDC)

E. Jeffrey Greenberg, MD

Registration

Related Resources

Treatment Pathways Across Cultures: Audience Q&A

Part 2: Introduction to PTSD

Identification of Agitation in Patients with Dementia due to Alzheimer’s Disease: Perspectives from the Primary Care Provider

Event Navigation

Join today for instant access to all PsychU content, events, and more!

Membership is free!

Choose Your Unique Login

I AGREE TO THE FOLLOWING TERMS

Event Registration

Join PsychU Today to receive a wide array of tools and benefits

Stay Connected: